Bin-Hui Xie (Binhui Xie)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Signaling Pathway

Top Venues

BioMed research international

Cell biology international

This page only lists publications with an associated author ORCID identifier.

Publications

Yuankang Xie, Heping Li, Baiyin Zhong, Xiansen Zhu, Rong Ye, Bin-Hui Xie, Jianhong Zhang
SPRR3 Contributes to Aggressiveness of Pancreatic Cancer Cells via NF- κ B Signaling Pathway. BioMed research international 2023 (2023)
Yuankang Xie, Heping Li, Baiyin Zhong, Xiansen Zhu, Rong Ye, Bin-Hui Xie, Jianhong Zhang
SPRR3 Contributes to Aggressiveness of Pancreatic Cancer Cells via NF- κ B Signaling Pathway. BioMed research international 2023 (2023)
Liang Peng, Rong Ye, Xiansen Zhu, Yuankang Xie, Baiyin Zhong, Yao Liu, Heping Li, Bin-Hui Xie
LINC02273 Promotes Hepatocellular Carcinoma Progression via Retaining β -Catenin in the Nucleus to Augment Wnt Signaling. BioMed research international 2022 (2022)
Hong-Fu Liu, Yuan-Kang Xie, Bai-Yin Zhong, Jian-Hong Zhang, Cai-Xin Song, Yu-Wen Liu, Yan Yang, Bin-Hui Xie
Dipeptidyl peptidase-8 induces sorafenib resistance via binding with c-Rel to mediate NF-κB signaling in hepatocellular carcinoma. Cell biology international (2021)
Qing-Quan Liu, Yu-Wen Liu, Yuan-Kang Xie, Jian-Hong Zhang, Cai-Xin Song, Jian-Zhong Wang, Bin-Hui Xie
Amplification of DDR2 mediates sorafenib resistance through NF-κB/c-Rel signaling in hepatocellular carcinoma. Cell biology international 45 (9) (2021)